CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-01 | Kelderman Kim Pres. Diagnostics & Genom | Shares withheld for taxes | −821 | $227.54 | $187K | 1,668 |
| 2020-05-01 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise · Restricted Stock Units | −1,666 | 1,667 | ||
| 2020-04-30 | WIENS HAROLD J Director | Option exercise | +4,000 | $91.78 | $367K | 9,221 |
| 2020-04-30 | WIENS HAROLD J Director | Sale | −4,000 | $225.00 | $900K | 5,221 |
| 2020-04-30 | WIENS HAROLD J Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 | ||
| 2020-03-04 | Eansor Norman David President-Protein Sciences | Sale | −1,387 | $198.68 | $276K | 0 |
| 2020-02-12 | HIGGINS JOHN L Director | Option exercise | +5,000 | $61.46 | $307K | 9,021 |
| 2020-02-12 | HIGGINS JOHN L Director | Sale | −5,000 | $205.23 | $1.0M | 4,021 |
| 2020-02-12 | HIGGINS JOHN L Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2020-01-06 | Kummeth Charles R. Chief Executive Officer | Option exercise | +10,276 | $67.46 | $693K | 140,265 |
| 2020-01-06 | Kummeth Charles R. Chief Executive Officer | Sale | −10,276 | $217.28 | $2.2M | 129,989 |
| 2020-01-06 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −10,276 | 100 | ||
| 2020-01-03 | Kummeth Charles R. Chief Executive Officer | Option exercise | +7,999 | $67.46 | $540K | 137,988 |
| 2020-01-03 | Kummeth Charles R. Chief Executive Officer | Sale | −6,258 | $217.37 | $1.4M | 131,730 |
| 2020-01-03 | Kummeth Charles R. Chief Executive Officer | Sale | −1,741 | $218.23 | $380K | 129,989 |
| 2020-01-03 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −7,999 | 10,376 | ||
| 2020-01-02 | Kummeth Charles R. Chief Executive Officer | Option exercise | +19,843 | $67.46 | $1.3M | 149,832 |
| 2020-01-02 | Kummeth Charles R. Chief Executive Officer | Sale | −6,449 | $217.40 | $1.4M | 143,383 |
| 2020-01-02 | Kummeth Charles R. Chief Executive Officer | Sale | −3,282 | $218.42 | $717K | 140,101 |
| 2020-01-02 | Kummeth Charles R. Chief Executive Officer | Sale | −9,245 | $219.32 | $2.0M | 130,856 |
Page 46 of 53 · 1,043 trades